English

25 MAY
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PARTICIPANTS PROFILE

Product categories

Branded generics: 48.3%

Biological products: 43.3%

Biosimilars: 26.7%

Hospital products: 40.0%

Innovative medicines: 58.7%

more info




Partnering Strategy/Interests

In-licensing: 46.7%

Out-licensing: 40.0%

Co-marketing: 31.7%

Co-promotion: 26.7%

Co-development: 46.7%

more info




Therapeutic areas

Cardiovascular: 40.0%

CNS: 45.0%

Infectious diseases: 35.0%

Pain: 41.7%

Respiratory: 33.3%

more info



PARTICIPANTS 2016

Branded generics: 48.3%

Biological products: 43.3%

Biosimilars: 26.7%

Diagnostics: 7.5%

Distribution: 12.5%

Drug delivers technol.: 0.0%

Generics: 25.8%

Herbal medicines: 17.5%

Homeopathy: 5.0%

Hospital products: 40.0%

Innovative medicines: 58.7%

Medical devices: 19.2%

Veterinary: 8.3%

partner